Skip to main content

Dr. Boccaccio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Boccaccio's full profile

Already have an account?

  • Office

    3201 Matlock Road
    Suite 220
    Arlington, TX 76015
    Phone+1 682-282-6648

Summary

  • Dr. Brad Boccaccio is a board certified Ob/Gyn. He was born and raised in Austin, Texas. He earned his Bachelor of Arts degree in psychology at the University of North Texas in Denton and graduated summa cum laude in 2010. He graduated from the University of North Texas Health Science Center in Fort Worth in 2015 and then moved to Oklahoma with his wife (and dogs) to pursue his Ob/Gyn residency at the University of Oklahoma Health Science Center in Oklahoma City.

    During his residency, Dr. Boccaccio received the Resident Teaching Award four consecutive years in a row, won "Best Quality Improvement Award", earned his certification on the da Vinci robotic surgical system, and published articles in various peer-reviewed journals. During his final year of training he was named Outstanding MIS Resident and was honored with the Resident Achievement Award from the Society of Laparoendoscopic Surgeons. He was also recognized by the American Association of Gynecologic Laparoscopists for Excellence in Minimally Invasive Gynecology and received the Senior Resident Award for Evidence Based Medicine. He believes in patient-centered, evidence based medicine and works diligently to stay up to date on the most recent developments in the field so that he can act as a resource for his patients.

    Dr. Boccaccio's scope of practice includes routine and high-risk obstetrical care, well-woman care, transition to menopause, contraception management, full spectrum gynecology, and minimally-invasive and robotic-assisted surgical procedures including hysterectomy and myomectomy.

    When he is not in the office, on L&D, or in the operating room, he can usually be found working around his house, spending time with his wife Rachel and their sons Oliver and Elliott, or at the ballpark cheering on the Texas Rangers.

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 2015 - 2019
  • UNTHSC Texas College of Osteopathic Medicine
    UNTHSC Texas College of Osteopathic MedicineClass of 2015, DO
  • University of North Texas Health Science Center
    University of North Texas Health Science CenterMS, Biomedical Sciences, 2010 - 2011
  • University of North Texas
    University of North TexasBA, Psychology, minors in biology and chemistry, Summa Cum Laude, 2006 - 2010

Certifications & Licensure

  • OK State Medical License
    OK State License 2016 - 2025
  • TX State Medical License
    TX State License 2019 - 2025
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Heart AssociationAdvanced Cardiac Life Support
  • American Heart AssociationBasic Life Support
  • Intuitive SurgicalDaVinci Robotics Certification
  • Intuitive SurgicalDaVinci Si Modules for Surgeons

Awards, Honors, & Recognition

  • Recognition of Excellence in Minimally Invasive Gynecology American Association of Gynecologic Laparoscopists, 2019
  • Outstanding MIS Resident Achievement Award The Society of Laparoendoscopic Surgeons, 2019
  • Senior Resident Award for Evidence Based Medicine University of Oklahoma HSC Department of Ob/Gyn, 2019
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Surgical Complexity Score and Role of Laparoscopy In Women With Advanced Ovarian Cancer Treated With Neoadjuvant Chemotherapy  
    Davidson, B., Broadwater, G., Crim, A., Boccaccio, B., Bixel, K., Backes, F., Previs, R., Salinaro, J., Salani, R., Moore, K., Secord, A., Gynecologic Oncology, Vol. 152, Issue 3, Pg. 554-559, 3/2019
  • Opioid Pain Medication Use in Urogynecology and Gynecology Patients  
    Dwarica, D., Boccaccio, B., Rubenstein, A., Motwani, A., Peck, J., Quiroz, L, Female Pelvic Medicine & Reconstructive Surgery, Vol. 25 (2), 9/20/2018

Abstracts/Posters

  • Rate of Venous Thromboembolism During Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
    Salinaro, J., Boccaccio, B., Ehrisman, J., Harvilesky, L., Secord, A., Moore, K., Davidson, B., Society of Gynecologic Oncology Annual Meeting, Honolulu, HI, 3/17/2019
  • Factors That Predict Optimal Debulking at Interval Cytoreductive Surgery After Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
    Boccaccio, B., Crim, A., Osborn, K., Ding, K., Moore, K., Gynecologic Oncology 149 (2018) 82, 6/2018
  • Factors That Predict Optimal Debulking at Interval Cytoreductive Surgery After Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
    Boccaccio, B., Crim, A., Osborn, K., Ding, K., Moore, K, Society of Gynecologic Oncologists Annual Meeting, New Orleans, LA, 3/2018

Press Mentions

  • Brad Boccaccio, DO, MS
    Brad Boccaccio, DO, MSJuly 19th, 2020

Committees

  • Member, Medical City Arlington Surgery Advisory Board 2020 - Present
  • Member, Medical City Arlington Robotics Clinical Excellence Committee 2020 - Present
  • Member, Medical City Arlington Maternal Safety Workgroup 2020 - Present
  • Member, University of Oklahoma Clinical Care Provider/Shared Governance Council 2017 - 2019
  • Member, University of Oklahoma Ob/Gyn Residency Admissions Committee 2016 - 2019
  • Member, University of Oklahoma Medical Center MD-RN Council 2016 - 2017

Research History

  • Factors That Predict Optimal Debulking at Interval Cytoreductive Surgery After Neoadjuvant Chemotherapy in Epithelial Ovarian CancerEvaluation of factors that predict optimal debulking at interval cytoreductive surgeries for ovarian cancer patients.2017 - 2019
  • Opioid Pain Medication Use in New Urogynecology PatientsRetrospective prevalence study regarding opioid pain medication use in general gynecology patients vs. those seen in urogynecology/FPMRS clinics.2017 - 2018

Professional Memberships